These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 37330181)
1. Rational design of novel microtubule targeting anticancer drugs N-imidazopyridine noscapinoids: Chemical synthesis and experimental evaluation based on in vitro using breast cancer cells and in vivo using xenograft mice model. Pragyandipta P; Pedapati RK; Reddy PK; Nayek A; Meher RK; Guru SK; Kantevari S; Naik PK Chem Biol Interact; 2023 Sep; 382():110606. PubMed ID: 37330181 [TBL] [Abstract][Full Text] [Related]
2. Rational design, chemical synthesis and cellular evaluation of novel 1,3-diynyl derivatives of noscapine as potent tubulin binding anticancer agents. Patel AK; Meher RK; Reddy PK; Pedapati RK; Pragyandipta P; Kantevari S; Naik MR; Naik PK J Mol Graph Model; 2021 Jul; 106():107933. PubMed ID: 33991960 [TBL] [Abstract][Full Text] [Related]
3. Rational design of novel N-alkyl amine analogues of noscapine, their chemical synthesis and cellular activity as potent anticancer agents. Meher RK; Pragyandipta P; Pedapati RK; Nagireddy PKR; Kantevari S; Nayek AK; Naik PK Chem Biol Drug Des; 2021 Sep; 98(3):445-465. PubMed ID: 34051055 [TBL] [Abstract][Full Text] [Related]
4. Development of 1,3-diynyl derivatives of noscapine as potent tubulin binding anticancer agents for the management of breast cancer. Meher RK; Pragyandipta P; Reddy PK; Pedaparti R; Kantevari S; Naik PK J Biomol Struct Dyn; 2022; 40(23):13136-13153. PubMed ID: 34583618 [TBL] [Abstract][Full Text] [Related]
13. 9-PAN promotes tubulin- and ROS-mediated cell death in human triple-negative breast cancer cells. Verma P; Nagireddy PKR; Prassanawar SS; Nirmala JG; Gupta A; Kantevari S; Lopus M J Pharm Pharmacol; 2020 Nov; 72(11):1585-1594. PubMed ID: 32959391 [TBL] [Abstract][Full Text] [Related]
14. Rational design of 9-vinyl-phenyl noscapine as potent tubulin binding anticancer agent and evaluation of the effects of its combination on Docetaxel. Dash SG; Suri C; Nagireddy PKR; Kantevari S; Naik PK J Biomol Struct Dyn; 2021 Sep; 39(14):5276-5289. PubMed ID: 32608323 [TBL] [Abstract][Full Text] [Related]
15. Tubulin- and ROS-dependent antiproliferative mechanism of a potent analogue of noscapine, N-propargyl noscapine. Nambiar N; Nagireddy PKR; Pedapati R; Kantevari S; Lopus M Life Sci; 2020 Oct; 258():118238. PubMed ID: 32791146 [TBL] [Abstract][Full Text] [Related]
16. Synergistic interaction of N-3-Br-benzyl-noscapine and docetaxel abrogates oncogenic potential of breast cancer cells. Dash SG; Kantevari S; Pandey SK; Naik PK Chem Biol Drug Des; 2021 Sep; 98(3):466-479. PubMed ID: 34107169 [TBL] [Abstract][Full Text] [Related]
17. Induction of microtubule hyper stabilization and robust G Verma P; Manchukonda NK; Kantevari S; Lopus M Fundam Clin Pharmacol; 2021 Dec; 35(6):955-967. PubMed ID: 33576046 [TBL] [Abstract][Full Text] [Related]
18. A Novel Class of N-Sulfonyl and N-Sulfamoyl Noscapine Derivatives that Promote Mitotic Arrest in Cancer Cells. Yong C; Devine SM; Gao X; Yan A; Callaghan R; Capuano B; Scammells PJ ChemMedChem; 2019 Dec; 14(23):1968-1981. PubMed ID: 31714012 [TBL] [Abstract][Full Text] [Related]
19. Combined molecular dynamics and continuum solvent approaches (MM-PBSA/GBSA) to predict noscapinoid binding to γ-tubulin dimer. Suri C; Naik PK SAR QSAR Environ Res; 2015 Jun; 26(6):507-19. PubMed ID: 26274780 [TBL] [Abstract][Full Text] [Related]
20. Noscapinoids with anti-cancer activity against human acute lymphoblastic leukemia cells (CEM): a three dimensional chemical space pharmacophore modeling and electronic feature analysis. Naik PK; Santoshi S; Joshi HC J Mol Model; 2012 Jan; 18(1):307-18. PubMed ID: 21523542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]